Transvaginal PVDF-mesh for cystocele repair A cohort study /
Introduction Optimized biocompatibility of new materials is a major requirement for transvaginal meshes for pelvic organ prolapse (POP) repair. Polyvinylidene fluoride (PVDF) presented good characteristics in prior animal experiments and clinical use in humans. Methods Between 01/2012 and 04/2016 37...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
Elsevier
2017
|
| Sorozat: | INTERNATIONAL JOURNAL OF SURGERY
39 |
| doi: | 10.1016/j.ijsu.2017.02.006 |
| mtmt: | 3195027 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/11732 |
| LEADER | 02385nab a2200277 i 4500 | ||
|---|---|---|---|
| 001 | publ11732 | ||
| 005 | 20191022125927.0 | ||
| 008 | 170706s2017 hu o 0|| zxx d | ||
| 022 | |a 1743-9191 | ||
| 024 | 7 | |a 10.1016/j.ijsu.2017.02.006 |2 doi | |
| 024 | 7 | |a 3195027 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a zxx | ||
| 100 | 1 | |a Barski Dimitri | |
| 245 | 1 | 0 | |a Transvaginal PVDF-mesh for cystocele repair |h [elektronikus dokumentum] : |b A cohort study / |c Barski Dimitri |
| 260 | |a Elsevier |c 2017 | ||
| 300 | |a 249-254 | ||
| 490 | 0 | |a INTERNATIONAL JOURNAL OF SURGERY |v 39 | |
| 520 | 3 | |a Introduction Optimized biocompatibility of new materials is a major requirement for transvaginal meshes for pelvic organ prolapse (POP) repair. Polyvinylidene fluoride (PVDF) presented good characteristics in prior animal experiments and clinical use in humans. Methods Between 01/2012 and 04/2016 37 women underwent transvaginal repair of symptomatic prolapse of the anterior vaginal wall (cystocele) with PVDF-mesh in a single institution. A chart review for recurrence, continence, peri- and early postoperative complications was performed. Referring practitioners were interviewed by telephone and mail. Additionally patient reported outcome and satisfaction were measured by Patient Global Improvement Inventory (PGI-I) scale. Results 34 women were eligible for a mean follow up of 19 months. The functional outcome improved significantly. One symptomatic vault prolapse (2.9%) and two reoperations for incontinence (5.9%) occurred. Two mesh exposures (5.9%) occurred and were treated conservatively. No other severe complications were registered. 87.5% of treated women felt very much better or much better and would undergo the surgery again. A cohort study including development steps in accordance with the IDEAL system is presented. Conclusions For the first time we report on effectivity and safety of transvaginal application of PVDF-mesh in real-life practice. A prospective long-term evaluation in a registry is justified. © 2017 IJS Publishing Group Ltd | |
| 700 | 0 | 1 | |a Arndt Christian |e aut |
| 700 | 0 | 1 | |a Gerullis Holger |e aut |
| 700 | 0 | 1 | |a Yang Jin |e aut |
| 700 | 0 | 1 | |a Boros Mihály |e aut |
| 700 | 0 | 1 | |a Otto Thomas |e aut |
| 700 | 0 | 1 | |a Kolberg Hans-Christian |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/11732/1/Barski_etal_2017_Int_J_Surg_u.pdf |z Dokumentum-elérés |